📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Resmed Inc

Common Name
Resmed
Country
United States
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,600
Ticker
RMD
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producin...

Resmed's GHG Emissions Data Preview

In 2025, Resmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Resmed has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=RMD&reporting_period=2024"

Verified Sources Behind Resmed’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Resmed’s data sources below and access millions more through our Disclosure Search.

a. Resmed's Sustainability Report 2024
a. Resmed's Sustainability Report 2024
b. Resmed's Sustainability Report 2023
b. Resmed's Sustainability Report 2023

Insights into Resmed's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions ofResmed amounted to27,530metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Resmeddecreased by 3.94%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Resmed's Scope 1 Emissions Over Time

2021202220232024202501.5 k3 k4.5 k6 ktCO2e+55%+19%-5%-7%
  • Total Scope 1
  • Year-over-Year Change

What are Resmed's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Resmed were 3,957 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Has Resmed reduced its Scope 1 emissions over time?

Since 2021, Resmed's Scope 1 emissions have increased by 63.65%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year(2024), Resmed's Scope 1 emissions decreased by 6.59%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Resmed's Scope 2 emissions?

In 2025, Resmed reported Scope 2 greenhouse gas (GHG) emissions of 23,573 tCOâ‚‚e without specifying the calculation method.a

Has Resmed reduced its Scope 2 emissions over time?

Since 2021, Resmed's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method)have remained relatively stable, indicating that Resmed's emissions have plateaued with no significant change in its energy consumption footprint.ab

Compared to the previous year(2024), Resmed's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Resmed's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Resmed use for Scope 2 reporting?

In 2025, Resmed reported its Scope 2 emissions using an unspecified methodology.a

Resmed's Scope 2 Emissions Over Time

2021202220232024202506.5 k13 k19.5 k26 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Resmed’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Resmed reported Scope 1 greenhouse gas (GHG) emissions of 3,957 tCOâ‚‚e and total revenues of USD 5,146 millions. This translates into an emissions intensity of 0.77 tCOâ‚‚e per millions USD.a

Resmed's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000100,0001,000,000Scope 1 Emissions (tCO2e)2005002,00010,00050,000Revenues (Millions of USD)SIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MAzentaYear: 2024Scope 1: 4,147 tCO2eRevenue: $M 656Scope 1 Intensity: 6.32 tCO2e/$MAptargroupYear: 2024Scope 1: 24,805 tCO2eRevenue: $M 3,583Scope 1 Intensity: 6.92 tCO2e/$MAvantorYear: 2024Scope 1: 39,502 tCO2eRevenue: $M 6,784Scope 1 Intensity: 5.82 tCO2e/$MBecton Dickinson and CoYear: 2024Scope 1: 176,565 tCO2eRevenue: $M 20,178Scope 1 Intensity: 8.75 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MWest Pharmaceutical ServicesYear: 2024Scope 1: 31,327 tCO2eRevenue: $M 2,893Scope 1 Intensity: 10.83 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MCooper CompaniesYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 3,895Scope 1 Intensity: 14.93 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MZoetisYear: 2024Scope 1: 101,392 tCO2eRevenue: $M 9,256Scope 1 Intensity: 10.95 tCO2e/$MHenry ScheinYear: 2024Scope 1: 33,555 tCO2eRevenue: $M 12,673Scope 1 Intensity: 2.65 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2024Scope 1: 2,875 tCO2eRevenue: $M 1,357Scope 1 Intensity: 2.12 tCO2e/$MQuest DiagnosticsYear: 2024Scope 1: 111,724 tCO2eRevenue: $M 9,872Scope 1 Intensity: 11.32 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MSSSolventumYear: 2024Scope 1: 146,000 tCO2eRevenue: $M 8,254Scope 1 Intensity: 17.69 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MResmedYear: 2025Scope 1: 3,957 tCO2eRevenue: $M 5,146Scope 1 Intensity: 0.77 tCO2e/$M

How does Resmed's GHG emissions intensity compare to its peers?

In 2025, Resmed reported a Scope 1 emissions intensity of 0.77 tCOâ‚‚e per millions USD. Compared to the peer group median of 5.49, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Resmed rank on GHG emissions intensity within its industry?

In 2025, Resmed ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Resmed among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Resmed's GHG Emissions Dataset?
Sign Up